Physician profile
Amy Thomas
NPI 1114815685
$721.91
in general payments reported to CMS, 2019-2025
10 companies · $722 in 2025
The $722 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $211.38 | 2025 | Camzyos |
| Bridgebio Pharma, INC. | $120.85 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $109.15 | 2025 | Amvuttra, Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.93 | 2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $69.19 | 2025 | |
| Novo Nordisk INC | $42.51 | 2025 | Wegovy |
| Tactile Systems Technology INC | $23.60 | 2025 | Nimbl, Flexitouch Plus |
| Glaxosmithkline, LLC. | $16.91 | 2025 | Arexvy, Shingrix |
| Genzyme Corporation | $15.55 | 2025 | |
| Edwards Lifesciences Corporation | $14.84 | 2025 | Evoque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.